NO761101L - - Google Patents

Info

Publication number: NO761101L
Authority: NO; Norway
Prior art keywords: preparation; preparation according; carrier component; colon; salts
Prior art date: 1975-04-09

Application number

NO761101A

Other languages

English (en)

Norwegian (no)

Inventor

C H Appelgren

C B Bogentoft

J A Sjoegren

Original Assignee

Haessle Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1975-04-09

Filing date

1976-03-30

Publication date

1976-10-12

1976-03-30 Application filed by Haessle Ab filed Critical Haessle Ab

1976-10-12 Publication of NO761101L publication Critical patent/NO761101L/no

Links

238000002360 preparation method Methods 0.000 claims abstract description 21
210000001072 colon Anatomy 0.000 claims abstract description 12
239000003795 chemical substances by application Substances 0.000 claims description 12
239000000126 substance Substances 0.000 claims description 12
150000001875 compounds Chemical class 0.000 claims description 9
229920002125 Sokalan® Polymers 0.000 claims description 8
208000002551 irritable bowel syndrome Diseases 0.000 claims description 8
238000000034 method Methods 0.000 claims description 8
230000008961 swelling Effects 0.000 claims description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
239000001913 cellulose Substances 0.000 claims description 6
235000010980 cellulose Nutrition 0.000 claims description 6
229920002678 cellulose Polymers 0.000 claims description 6
239000008187 granular material Substances 0.000 claims description 6
239000004584 polyacrylic acid Substances 0.000 claims description 6
239000011230 binding agent Substances 0.000 claims description 5
239000000463 material Substances 0.000 claims description 5
150000003839 salts Chemical class 0.000 claims description 5
238000010521 absorption reaction Methods 0.000 claims description 4
235000010410 calcium alginate Nutrition 0.000 claims description 4
239000000648 calcium alginate Substances 0.000 claims description 4
229960002681 calcium alginate Drugs 0.000 claims description 4
OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 4
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
238000004519 manufacturing process Methods 0.000 claims description 4
229920000642 polymer Polymers 0.000 claims description 4
244000215068 Acacia senegal Species 0.000 claims description 3
229920000084 Gum arabic Polymers 0.000 claims description 3
229920000148 Polycarbophil calcium Polymers 0.000 claims description 3
235000010489 acacia gum Nutrition 0.000 claims description 3
239000000205 acacia gum Substances 0.000 claims description 3
229950005134 polycarbophil Drugs 0.000 claims description 3
244000106483 Anogeissus latifolia Species 0.000 claims description 2
235000011514 Anogeissus latifolia Nutrition 0.000 claims description 2
239000001922 Gum ghatti Substances 0.000 claims description 2
235000019314 gum ghatti Nutrition 0.000 claims description 2
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 2
239000001768 carboxy methyl cellulose Substances 0.000 claims 2
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims 2
229920001027 sodium carboxymethylcellulose Polymers 0.000 claims 2
239000006096 absorbing agent Substances 0.000 claims 1
239000003960 organic solvent Substances 0.000 claims 1
235000002639 sodium chloride Nutrition 0.000 claims 1
206010013554 Diverticulum Diseases 0.000 description 9
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
210000001035 gastrointestinal tract Anatomy 0.000 description 5
206010013530 Diverticula Diseases 0.000 description 4
208000012258 Diverticular disease Diseases 0.000 description 4
235000011389 fruit/vegetable juice Nutrition 0.000 description 4
230000000968 intestinal effect Effects 0.000 description 4
210000000936 intestine Anatomy 0.000 description 4
210000002429 large intestine Anatomy 0.000 description 4
210000002784 stomach Anatomy 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 3
210000003608 fece Anatomy 0.000 description 3
-1 fibres Polymers 0.000 description 3
210000004051 gastric juice Anatomy 0.000 description 3
239000000203 mixture Substances 0.000 description 3
230000037023 motor activity Effects 0.000 description 3
230000001148 spastic effect Effects 0.000 description 3
235000015099 wheat brans Nutrition 0.000 description 3
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
206010010774 Constipation Diseases 0.000 description 2
229920000168 Microcrystalline cellulose Polymers 0.000 description 2
235000010451 Plantago psyllium Nutrition 0.000 description 2
244000090599 Plantago psyllium Species 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
208000007784 diverticulitis Diseases 0.000 description 2
235000013305 food Nutrition 0.000 description 2
229940016286 microcrystalline cellulose Drugs 0.000 description 2
235000019813 microcrystalline cellulose Nutrition 0.000 description 2
239000008108 microcrystalline cellulose Substances 0.000 description 2
229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 2
229920002689 polyvinyl acetate Polymers 0.000 description 2
239000011118 polyvinyl acetate Substances 0.000 description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
239000001267 polyvinylpyrrolidone Substances 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
230000008092 positive effect Effects 0.000 description 2
206010000060 Abdominal distension Diseases 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
239000001856 Ethyl cellulose Substances 0.000 description 1
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
229920000569 Gum karaya Polymers 0.000 description 1
229920002488 Hemicellulose Polymers 0.000 description 1
208000007107 Stomach Ulcer Diseases 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
230000001078 anti-cholinergic effect Effects 0.000 description 1
230000001142 anti-diarrhea Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
239000004067 bulking agent Substances 0.000 description 1
235000013339 cereals Nutrition 0.000 description 1
229960000541 cetyl alcohol Drugs 0.000 description 1
239000000812 cholinergic antagonist Substances 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
239000003814 drug Substances 0.000 description 1
235000006694 eating habits Nutrition 0.000 description 1
235000019325 ethyl cellulose Nutrition 0.000 description 1
229920001249 ethyl cellulose Polymers 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000945 filler Substances 0.000 description 1
230000003325 follicular Effects 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
150000002314 glycerols Chemical class 0.000 description 1
229940075507 glyceryl monostearate Drugs 0.000 description 1
239000003979 granulating agent Substances 0.000 description 1
BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
229920000058 polyacrylate Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000008247 solid mixture Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
230000002048 spasmolytic effect Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000009747 swallowing Effects 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)

NO761101A 1975-04-09 1976-03-30 NO761101L (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE7504049A SE7504049L (sv)	1975-04-09	1975-04-09	Colonpreparation

Publications (1)

Publication Number	Publication Date
NO761101L true NO761101L (fr)	1976-10-12

Family

ID=20324216

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO761101A NO761101L (fr)	1975-04-09	1976-03-30

Country Status (12)

Country	Link
BE (1)	BE840552A (fr)
DE (1)	DE2614296A1 (fr)
DK (1)	DK153376A (fr)
FI (1)	FI56772C (fr)
FR (1)	FR2306710A1 (fr)
GB (1)	GB1538123A (fr)
IE (1)	IE42793B1 (fr)
LU (1)	LU74732A1 (fr)
NL (1)	NL7603600A (fr)
NO (1)	NO761101L (fr)
NZ (1)	NZ180552A (fr)
SE (1)	SE7504049L (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS52139715A (en) *	1976-05-14	1977-11-21	Nippon Kayaku Co Ltd	Coated granules of alkali polyacrylate
FR2471186A1 (fr) *	1979-12-10	1981-06-19	Roussel Uclaf	Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
US4444761A (en) *	1981-05-04	1984-04-24	Syntex (U.S.A.) Inc.	Cellulose/carboxymethyl cellulose mixtures useful for controlling fecal output, and methods employing them
US4461759A (en) *	1983-01-03	1984-07-24	Verex Laboratories, Inc.	Constant release rate solid oral dosage formulations of veropamil
US4522804A (en) *	1983-01-03	1985-06-11	Verex Laboratories, Inc.	Constant release rate solid oral dosage formulations of propranolol
US4521401A (en) *	1983-01-03	1985-06-04	Verex Laboratories, Inc.	Constant release rate solid oral dosage formulations of quinidine
EP0273209B1 (fr) *	1986-12-30	1992-01-15	American Cyanamid Company	Composition contenant un polycarbophile
GB8817015D0 (en) *	1988-07-16	1988-08-17	Reckitt & Colmann Prod Ltd	Method of treatment
DE3931215C2 (de) *	1988-09-20	1998-07-16	Glaxo Group Ltd	Pharmazeutische Präparate auf der Grundlage von Ranitidin
HU210497B (en) *	1990-05-04	1995-04-28	Perio Prod Ltd	Process for production of modified pectin
IL98087A (en) *	1990-05-04	1996-11-14	Perio Prod Ltd	Preparation for dispensing drugs in the colon
DE9212938U1 (de) *	1992-09-25	1992-11-26	Boehringer Ingelheim Gmbh, 6507 Ingelheim	Calciumpolycarbophil-Zubereitung zur Einnahme hoher Wirkstoffdosen
US5840332A (en) *	1996-01-18	1998-11-24	Perio Products Ltd.	Gastrointestinal drug delivery system
WO2018191752A1 (fr)	2017-04-14	2018-10-18	Gelesis Llc	Compositions et méthodes pour le traitement ou la prévention de troubles liés à la perméabilité intestinale

1975
- 1975-04-09 SE SE7504049A patent/SE7504049L/xx unknown
1976
- 1976-03-30 NO NO761101A patent/NO761101L/no unknown
- 1976-03-31 DK DK153376A patent/DK153376A/da not_active IP Right Cessation
- 1976-04-02 DE DE19762614296 patent/DE2614296A1/de not_active Withdrawn
- 1976-04-06 NL NL7603600A patent/NL7603600A/xx not_active Application Discontinuation
- 1976-04-07 FI FI760948A patent/FI56772C/fi not_active IP Right Cessation
- 1976-04-08 FR FR7610342A patent/FR2306710A1/fr active Granted
- 1976-04-08 NZ NZ180552A patent/NZ180552A/xx unknown
- 1976-04-08 GB GB14390/76A patent/GB1538123A/en not_active Expired
- 1976-04-09 IE IE749/76A patent/IE42793B1/en unknown
- 1976-04-09 LU LU74732A patent/LU74732A1/xx unknown
- 1976-04-09 BE BE165981A patent/BE840552A/fr unknown

Also Published As

Publication number	Publication date
LU74732A1 (fr)	1977-02-04
FR2306710A1 (fr)	1976-11-05
FI56772C (fi)	1980-04-10
IE42793L (en)	1976-10-09
FI760948A7 (fr)	1976-10-10
BE840552A (fr)	1976-10-11
IE42793B1 (en)	1980-10-22
DE2614296A1 (de)	1976-10-21
GB1538123A (en)	1979-01-10
NL7603600A (nl)	1976-10-12
FI56772B (fi)	1979-12-31
NZ180552A (en)	1978-07-28
FR2306710B1 (fr)	1979-07-13
DK153376A (da)	1976-10-10
SE7504049L (sv)	1976-10-10

Publication	Publication Date	Title
JPH11509547A (ja)	1999-08-24	Ｌ−ドーパエチルエステルの医薬組成品
WO1984000104A1 (fr)	1984-01-19	Comprimes de propranolol a diffusion entretenue
JPH045647B2 (fr)	1992-02-03
WO2015081887A1 (fr)	2015-06-11	Composition pharmaceutique d'hydroxyde de calcium-montmorillonite acide, préparation, produit et application
IE42793B1 (en)	1980-10-22	Preparation for treatment of colitis
RS50104B (sr)	2009-01-22	Nova oralna formulacija za 5-th4 agoniste ili antagoniste
CN101647785B (zh)	2011-12-07	格列齐特缓释片及其制备方法
CN101416947A (zh)	2009-04-29	复方α-酮酸咀嚼片及制备方法
FR2904774A1 (fr)	2008-02-15	Composition pharmaceutique solide contenant une combinaison d'un agent regulateur de la motilite intestinale et d'un antiflatulent.
CN114146062B (zh)	2023-07-28	一种组合物及其制备方法和用途
CN101715448B (zh)	2013-06-19	一种咪唑-5-羧酸衍生物的治疗用途
CN101491493A (zh)	2009-07-29	阿魏酸哌嗪缓释药物制剂
CN101590031B (zh)	2011-10-12	磺化去氢松香酸二钠组合物的制备方法
US3211615A (en)	1965-10-12	Oral antidiabetic composition and method of use
JPS62207212A (ja)	1987-09-11	抗アレルギ−剤
CN115804802B (zh)	2023-10-20	泽漆挥发油在治疗细菌性肠炎疾病药物中的应用
CN114748437B (zh)	2024-10-25	一种瑞巴派特胃漂浮片及其制备方法
CN103356630B (zh)	2016-08-03	含有己酮可可碱和普卡必利的药物组合物及其医药用途
CN113274365B (zh)	2021-10-22	雷美替胺速释缓释双释放制剂及其制备方法
Krishnaswamy et al.	1970	Mental changes and platelet serotonin in pellagrins
Marks	1949	Cellulose esters in the treatment of constipation
CN101406496A (zh)	2009-04-15	一种治疗前列腺炎及其它男性生殖系统疾病的配方
CN116712453B (zh)	2026-04-21	一种降尿酸组合物及其制备方法
WO2020104987A1 (fr)	2020-05-28	Composition destinée à être utilisée dans la prévention et/ou le traitement symptomatique du syndrome du côlon irritable
CN116850237A (zh)	2023-10-10	润肠通便的中药组合物、其制备方法及应用